Week In Review: Cannabis Advocate Rep. Blumenauer Announces Retirement From Congress

Week In Review: Cannabis Advocate Rep. Blumenauer Announces Retirement From Congress
Week In Review: Cannabis Advocate Rep. Blumenauer Announces Retirement From Congress

On this week’s hashish information round-up, Oregon’s Rep. Blumenauer publicizes retirement after 27 years in Congress; New York expands medical hashish retail licenses to MSOs; and Switzerland launches first authorized hashish dispensary in Europe.

Rep. Blumenauer introducing the STATES Act in 2019. PHOTO Earl Blumenauer/Twitter

Rep. Blumenauer (D-OR) Retiring After 27 Years in Congress

Earl Blumenauer, a Democrat from Oregon who has served within the US Home of Representatives for 27 years, introduced on Monday that he is not going to search re-election.

In a press release, he mentioned it was a “troublesome determination” however that “it’s time to proceed my life’s mission with out the burden of day-to-day politics.”

“I’ve devoted my profession to creating habitable communities the place persons are protected, wholesome and economically safe,” he mentioned within the launch. “This mission has guided my involvement in Congress on a variety of points. I’ll finest be identified in Portland for work on mild rail, streetcars and bicycles. However our work additionally included essential problems with struggle and peace, championing the combat to finish the failed Warfare on Medication, serving to to put in writing the Inexpensive Care Act, rescuing unbiased eating places, meals and farm coverage, animal welfare and writing the one largest funding in renewable vitality in historical past.”  

Blumenauer is a founding member of the Congressional Hashish Caucus and a vocal advocate for federal hashish reform. He has been a key supporter of the SAFE Banking Act and the MORE Act, each of which might’ve legalized hashish on the federal stage.

Along with his work on hashish reform, Blumenauer has additionally been a frontrunner on points akin to transportation, healthcare and local weather change.

PHOTO Jerry Ferguson

New York Expands Medical Hashish Retail Licenses to MSOs

New York is expanding medical hashish retail licenses to giant multistate operators (MSOs) for the primary time for the reason that state launched MMJ gross sales in January 2016. The applying window opened on October 31 and can run till December 19.

This transfer is more likely to divide licensed adult-use retailers in addition to lots of of Conditional Grownup-Use Retail Dispensary (CAURD) licensees and candidates who’ve been attempting to open shops for months. Nonetheless, the Workplace of Hashish Administration (OCM) is hoping that the addition of MSOs will assist to spice up the state’s nascent adult-use market, which has been gradual to start out.

New York has one of many largest hashish markets within the US, however its adult-use market has been gradual to start out. As of November 3, 2023, there are solely 26 operational licensed adult-use retailers within the state.

The OCM hopes that including MSOs will increase the adult-use market. MSOs have the expertise and assets to open and function retail shops shortly. Additionally they have entry to a variety of hashish merchandise, which might assist to extend client selection.

The OCM will evaluate functions and make selections primarily based on the standard of the functions obtained and market wants. It’s unclear what number of licenses the OCM will award.

The addition of MSOs to the New York hashish market is a big improvement. It should possible have a significant influence on the Empire State’s adult-use market. It stays to be seen how the enlargement of licenses will have an effect on shoppers and companies.


Europe’s first authorized hashish dispensary has opened in Switzerland as a part of a pilot mission to check the results of managed entry to hashish. The dispensary, run by the Sanity Group and the Swiss Institute for Dependancy and Well being Analysis (ISGF), is positioned within the municipality of Allschwil, with one other location to comply with in Liestal.

“We’re happy in regards to the approval for the research in Baselland and the chance to make our contribution to social acceptance and information switch across the hashish plant and its versatile makes use of,” mentioned Finn Hänsel, CEO of Sanity Group, in a press release. “Our ambition to assist the ISGF pilot mission with our information and expertise as an internationally positioned hashish firm is based totally on the promotion of analysis within the subject of hashish. Because the firm was based, our purpose has been to additional analysis the advantages of hashish and destigmatize the plant. Along with the ISGF, we’re growing ideas for protected gross sales primarily based on well being safety, youth safety and prevention. We anticipate attention-grabbing findings from the research—the outcomes shall be of worldwide curiosity.”

As much as 3,950 wholesome adults dwelling within the Basel-Landschaft area will be capable to take part within the research. Contributors shall be given a participation card to acquire hashish from the dispensary and shall be frequently surveyed each six months on their consumption conduct and bodily and psychological well being.

The research, titled “Grashaus Tasks,” is scheduled to launch later this yr and is anticipated to offer worthwhile insights into the accountable use of hashish and function a foundation for selections on long-term regulation in Switzerland.

Like it? Share with your friends!



Your email address will not be published. Required fields are marked *